Detection and isolation of the following pathogenic organisms:
- E. coli – (USP <62> & *<2022>, *AOAC 991.14, FDA BAM Chapter 4, PCPC M-2)
- P. aeruginosa – (*USP <62> & PCPC M-2)
- Coagulase-positive Aureus – (USP <62> & *<2022>, FDA BAM Chapter 12, PCPC M-2)
- Salmonella Species – (USP <62> & *<2022>, FDA BAM Chapter 5, AOAC 2014.01, PCPC M-2)
- Listeria Species – (*FDA BAM Chapter 10, *AOAC RI030601, USDA MLG8.11)
- Monocytogenes – (*FDA BAM Chapter 10)
- Burkholderia Cepacia – (USP <60>)
- Klebsiella Pneumoniae – (ALSTMxxxx)
- Campylobacter Species – (FDA BAM Chapter 7)
- Alicyclobacillus Species – (APHA 25.6)
- Clostridium Species – (USP <62> & <2022>, FDA BAM Chapter 16)
- Bacillus Cereus – (FDA BAM Chapter 14)
- Candida Albicans – (USP <62>, PCPC M-2)
- Shigella Species – (FDA BAM Chapter 6)
- Shiga-toxin Producing E. Coli 0157:H7 – (STEC) – (FDA BAM Chapter 4a)
*Accredited to ISO standard 17025:2017 and listed in Advanced Laboratories scope AT-1573 (UT) and AT-1573.01 (NC).
